The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of genetic variants involved in drug metabolism and transport with efficacy and toxicity of chemotherapeutic treatment in osteosarcoma patients.
Hanneke I. Vos
No relevant relationships to disclose
Marieke J.H. Coenen
No relevant relationships to disclose
Hans Gelderblom
No relevant relationships to disclose
Tahar van der Straaten
No relevant relationships to disclose
Eveline S.J.M de Bont
No relevant relationships to disclose
Winette T.A. Van Der Graaf
No relevant relationships to disclose
H.W.B. Schreuder
No relevant relationships to disclose
Frank N. van Leeuwen
No relevant relationships to disclose
Henk-jan Guchelaar
No relevant relationships to disclose
Dunja Maroeska W.M. Te Loo
No relevant relationships to disclose